GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, ...
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has delivered the first patient doses of Flyrcadoâ„¢ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback